Home / Biosimilars

Biosimilars

News

Norwegian study may be slowing adoption of biosimilar infliximab posted 24/10/2014

Norway is funding clinical studies in which patients will be switched from originator biological drugs to biosimilars [1]. Ho...

Stada in-licenses teriparatide biosimilar posted 24/10/2014

German generics giant Stada Arzneimittel (Stada) announced on 13 October 2014 that it had made a deal to in-licensing a terip...

Merck KGaA plans further investment in biosimilars posted 24/10/2014

German pharma giant Merck KGaA announced on 18 September 2014 plans to step up investments in biosimilars during 2015.

Epirus and Livzon collaborate on copy biologicals for China posted 24/10/2014

US-based Epirus Biopharmaceuticals (Epirus) announced on 25 September 2014 that it had signed a collaboration agreement with...

Infliximab ‘similar biologic’ receives Indian approval posted 24/10/2014

US-based biologicals company Epirus Biopharmaceuticals (Epirus) announced on 15 September 2014 that it had received final mar...

 

Research

Extrapolation for biosimilars posted 24/10/2014

Regarding extrapolation* of indications for biosimilars, the European Medicines Agency (EMA) has stated that ‘if clinical sim...

Biosimilar bevacizumab similar to Avastin in preclinical assessments posted 24/10/2014

Preclinical assessments have demonstrated the similarity of biologicals major Amgen’s biosimilar bevacizumab candidate (ABP 2...

Mobilization of stem cells by biosimilar Nivestim and Neupogen posted 20/10/2014

Comparison of biosimilar granulocyte colony-stimulating factor (G-CSF), Nivestim and originator G-CSF, Neupogen (filgrastim),...

Phase III study of biosimilar adalimumab meets primary endpoint posted 10/10/2014

Biologicals major Amgen announced on 8 October 2014 the first late-stage data from its biosimilars programme. Primary efficac...

Strategy for biosimilars in China posted 06/10/2014

China is one of the largest pharmaceutical markets in the world, and has seen rapid growth in the biopharmaceuticals industry...

 

General

Biosimilars of epoetin alfa posted 24/10/2014

Last update: 17 October 2014Epoetin alfa is a human erythropoietin produced in cell culture using recombinant DNA technology....

IAPO releases toolkit for biologicals and biosimilars posted 24/10/2014

The International Alliance of Patients’ Organizations (IAPO), which comprises over 200 patient groups and represents the inte...

Biosimilars of adalimumab posted 24/10/2014

Adalimumab is a human monoclonal antibody that treats autoimmune diseases by inhibiting tumour necrosis factor (TNF); a solub...

Call for action on labelling of biosimilars posted 24/10/2014

European trade association, the European Association for Bioindustry (EuropaBio) has called on the European Medicines Agency...

Biosimilars applications under review by EMA – August 2014 posted 24/10/2014

The European Medicines Agency (EMA) is the body responsible for approval of biosimilars within the European Union (EU). A leg...

Generics News Research General

more

Biosimilars News Research General

more